Ursula Seidler Selected Research

Biomarkers (Surrogate Marker)

8/2018

A Phase 2, Randomized, Placebo-Controlled Study Evaluating Matrix Metalloproteinase-9 Inhibitor, Andecaliximab, in Patients With Moderately to Severely Active Crohn's Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ursula Seidler Research Topics

Disease

16	Inflammation (Inflammations) 09/2022 - 08/2006
11	Diarrhea 01/2022 - 08/2006
10	Cystic Fibrosis (Mucoviscidosis) 01/2024 - 02/2009
8	Colitis 01/2020 - 12/2007
7	Ulcerative Colitis 02/2023 - 07/2010
6	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 11/2005
5	Crohn Disease (Crohn's Disease) 10/2018 - 06/2010
5	Adenoma (Adenomas) 01/2012 - 03/2002
4	Body Weight (Weight, Body) 01/2019 - 11/2005
3	Acidosis 01/2021 - 10/2009
3	Hypertension (High Blood Pressure) 02/2009 - 08/2008
2	Asthma (Bronchial Asthma) 01/2024 - 10/2012
2	Neoplasms (Cancer) 06/2022 - 03/2011
2	Necrosis 01/2021 - 01/2017
1	Nasopharyngitis 02/2023
1	Acne Vulgaris 02/2023
1	Exanthema (Rash) 02/2023
1	Headache (Headaches) 02/2023
1	Rheumatic Diseases (Rheumatism) 01/2023
1	Constipation 09/2022
1	Intestinal Obstruction (Obstruction, Intestinal) 09/2022
1	Metaplasia 06/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Congenital chloride diarrhea 01/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022
1	Dysbiosis 01/2022
1	Behcet Syndrome (Behcet's Syndrome) 01/2020
1	Oral Ulcer (Mouth Ulcer) 01/2020
1	Fever (Fevers) 01/2020
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020
1	Nutrition Disorders (Nutritional Disorders) 01/2020
1	Ulcer 01/2020
1	Hyperaldosteronism (Conn Syndrome) 01/2019
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2019
1	Short Bowel Syndrome 01/2019
1	Ileitis 10/2018
1	Wounds and Injuries (Trauma) 07/2017

Drug/Important Bio-Agent (IBA)

8	CytokinesIBA 01/2022 - 09/2008
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2002
7	AnionsIBA 09/2023 - 03/2005
6	SaltsIBA 01/2018 - 08/2008
5	Phenobarbital (Luminal)FDA Link 01/2022 - 12/2007
5	ChloridesIBA 10/2020 - 08/2008
5	Sodium-Hydrogen ExchangersIBA 10/2019 - 05/2009
4	ElectrolytesIBA 10/2020 - 08/2006
4	Dextrans (Dextran)FDA Link 01/2020 - 12/2007
4	Dextran SulfateIBA 01/2020 - 09/2008
4	SodiumIBA 01/2019 - 12/2007
3	Sodium-Hydrogen Exchanger 3IBA 01/2022 - 10/2002
3	Messenger RNA (mRNA)IBA 01/2021 - 01/2012
3	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2020 - 12/2007
3	Protein Isoforms (Isoforms)IBA 01/2019 - 05/2009
3	Interleukin-23 (Interleukin 23)IBA 10/2018 - 11/2016
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2012 - 07/2010
3	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2012 - 01/2009
3	FructoseIBA 02/2009 - 08/2008
2	GLPG0634IBA 01/2023 - 01/2021
2	Bicarbonates (Hydrogen Carbonate)IBA 01/2022 - 04/2013
2	Tumor Necrosis Factor InhibitorsIBA 01/2021 - 01/2017
2	DipeptidesIBA 01/2020 - 01/2016
2	risankizumabIBA 10/2018 - 01/2017
2	Monoclonal AntibodiesIBA 01/2017 - 11/2016
2	ColforsinIBA 12/2012 - 01/2009
2	AcidsIBA 12/2012 - 10/2009
2	Epithelial Sodium ChannelsIBA 01/2012 - 04/2011
2	Phosphotransferases (Kinase)IBA 11/2010 - 10/2002
1	Niclosamide FDA Link 01/2024
1	BenzbromaroneIBA 01/2024
1	InterleukinsIBA 02/2023
1	spesolimabIBA 02/2023
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2023
1	tenapanorIBA 09/2022
1	Chloride Channels (Chloride Channel)IBA 09/2022
1	RNA (Ribonucleic Acid)IBA 06/2022
1	Antimicrobial PeptidesIBA 01/2022
1	Chloride-Bicarbonate AntiportersIBA 01/2022
1	carbonic anhydrase XIVIBA 01/2022
1	Protons (Proton)IBA 01/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	vedolizumabIBA 01/2021
1	Janus Kinase 1IBA 01/2021
1	Interleukin-17 (Interleukin 17)IBA 01/2020
1	HMGB1 Protein (HMG1)IBA 01/2020
1	Toll-Like Receptor 4IBA 01/2020
1	linaclotideIBA 01/2020
1	veltuzumabIBA 01/2020
1	Neutralizing AntibodiesIBA 01/2020
1	heat stable toxin (E coli)IBA 10/2019
1	Virulence Factors (Pathogenicity Factors)IBA 10/2019
1	AldosteroneIBA 01/2019
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 08/2018
1	andecaliximabIBA 08/2018
1	Biomarkers (Surrogate Marker)IBA 08/2018
1	Therapeutic UsesIBA 01/2018
1	Fluorescent Dyes (Fluorescent Probes)IBA 07/2017

Therapy/Procedure

6	Therapeutics 09/2022 - 11/2016
1	Lung Transplantation 01/2023
1	Intraperitoneal Injections 01/2020
1	Bariatric Surgery 01/2019